OGEN — Oragenics Cashflow Statement
0.000.00%
Last trade - 00:00
- $5.51m
- $2.34m
- $0.04m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -15.6 | -26.4 | -15.7 | -14.3 | -20.7 |
Depreciation | |||||
Non-Cash Items | 0.565 | 9.39 | 1.69 | 0.731 | 11.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.93 | 0.037 | 0.512 | -1.72 | 2.02 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -13 | -17 | -13.5 | -15.2 | -7.29 |
Capital Expenditures | -0.025 | 0 | -0.044 | -0.128 | -1 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | 0.012 | 0.064 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.025 | 0 | -0.044 | -0.116 | -0.936 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 11.1 | 16.3 | 23.1 | -0.495 | 0.284 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.94 | -0.628 | 9.63 | -15.8 | -7.94 |